SCALA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.246
EU - Europa 306
AS - Asia 42
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
OC - Oceania 1
Totale 1.602
Nazione #
US - Stati Uniti d'America 1.195
IT - Italia 127
SE - Svezia 96
GB - Regno Unito 52
CA - Canada 51
IN - India 17
UA - Ucraina 10
CN - Cina 7
RO - Romania 6
SG - Singapore 6
KR - Corea 4
DE - Germania 3
EU - Europa 3
FR - Francia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
ES - Italia 2
IR - Iran 2
NO - Norvegia 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
FI - Finlandia 1
ID - Indonesia 1
MD - Moldavia 1
MN - Mongolia 1
NL - Olanda 1
Totale 1.602
Città #
Chandler 326
Lawrence 97
Princeton 97
Ottawa 50
Wilmington 50
London 48
Des Moines 40
Chicago 39
Ashburn 35
Catanzaro 31
Napoli 16
Pune 8
Redmond 8
Marano 7
Seattle 7
Singapore 5
Augusta 4
Cosenza 4
Foggia 4
Latina 4
Luni 4
Naples 4
Norwalk 4
Seoul 4
Timisoara 4
Ann Arbor 3
Bangkok 3
Boardman 3
Derby 3
Ferrara 3
Reggio Calabria 3
Clearwater 2
Lowell 2
Milan 2
Montalto Uffugo 2
Nanchang 2
Oslo 2
Pontedera 2
Portici 2
Redwood City 2
Shanghai 2
Amsterdam 1
Ardabil 1
Buffalo 1
Burnaby 1
Chino Hills 1
Chisinau 1
Dallas 1
Dhaka 1
Fairfield 1
Giarre 1
Guangzhou 1
Hanover 1
Hebei 1
Helsinki 1
Horia 1
Hyderabad 1
Jakarta 1
La Canada Flintridge 1
Las Vegas 1
Los Angeles 1
Lucknow 1
Madrid 1
Milwaukee 1
Mountain View 1
Mumbai 1
Nashville 1
Perth 1
Reghin 1
Saint Paul 1
San Francisco 1
Santa Clara 1
Treviso 1
Turin 1
Ulaanbaatar 1
Vibo Valentia 1
Totale 973
Nome #
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 54
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 34
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 32
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 32
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 29
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 29
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 29
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 29
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 28
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 28
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 28
High efficiency of site-directed mutagenesis mediated by a single PCR product 27
AUTOCRINE GROWTH-FUNCTION OF HUMAN INTERLEUKIN-1 MOLECULES 26
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 26
HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enancer-binding protein beta (NF-IL6) transcription factors 25
Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis 25
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 25
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 25
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 24
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 24
Cancer-associated CD43 glycoforms as target of immunotherapy 24
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 23
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 23
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 23
Cancer-associated CD43 glycoforms as target of immunotherapy 23
Ultraviolet Mutagenesis 23
LYMPHOKINE ABNORMALITIES IN APLASTIC-ANEMIA - IMPLICATIONS FOR THE MECHANISM OF ACTION OF ANTITHYMOCYTE GLOBULIN 22
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 22
A new strategy for label-free detection of lymphoma cancer cells 22
Regulation of the HIV Promoter/Enhancer 21
An NF-κB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-κB-activating stimuli 21
Regulation of HIV-long terminal repeats by interactionof C/EBP(NF-IL6) and NF-kB/rel transcription factors 20
Regulation of NF-kappa B through the nuclear processing of p105 (NF-kappa B1) in Epstein-Barr virus-immortalized B cell lines 20
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 20
Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line 20
Perspectives for a protective HIV-1 vaccine 20
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 20
SEQUENTIAL INDUCTION OF C-MYC AND C-FOS MESSENGER-RNA TRANSCRIPTS DURING OKT3-INDUCED ACTIVATION OF T-CELLS 19
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .2. MODULATION OF CALCIUM FLUXES 19
INHIBITION BY ANTI-HLA CLASS-II MONOCLONAL-ANTIBODIES OF MONOCYTE-DEPENDENT T-CELL PROLIFERATION INDUCED BY MONOCLONAL-ANTIBODY OKT3 19
The aftermath of the Merck's HIV vaccine trial 19
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 19
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 19
THE HIV-1 TAT PROTEIN TRANSACTIVATES THE INTERLEUKIN-6 GENE 18
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 18
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 18
EFFECT OF INTERLEUKIN-1-BETA ON TRANSDUCING MECHANISMS IN 235-1 CLONAL PITUITARY-CELLS .1. MODULATION OF ADENYLATE-CYCLASE ACTIVITY 17
DECREASED INTERLEUKIN-1 PRODUCTION IN APLASTIC-ANEMIA 17
SUBSETS OF HUMAN LARGE GRANULAR LYMPHOCYTES (LGL) EXHIBIT ACCESSORY CELL FUNCTIONS 17
MUTAGENS ENHANCE THE HIV-1, INTERLEUKIN-1 (IL-1), AND INTERLEUKIN-6 (IL-6) EXPRESSION THROUGH TRANSCRIPTIONAL OR POSTTRANSCRIPTIONAL MECHANISMS 17
Site-directed mutagenesis mediated by a single polymerase chain reaction product 17
Identification and functional characterization of antigenic mimotopes of surface immunoglobulin from transformed B cells 17
HUMAN INTERLEUKIN-1 (IL1) STIMULATES THE GROWTH OF ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 16
INTERLEUKIN-INDUCED TUMOR IMMUNOGENICITY 16
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 16
Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line 15
EFFECTS OF RECOMBINANT INTERFERON-GAMMA ON HLA-DR ANTIGEN SHEDDING BY HUMAN PERIPHERAL-BLOOD ADHERENT MONONUCLEAR-CELLS 15
IMMUNOSUPPRESSIVE ACTIVITY OF BOVINE SEMINAL RNASE ON T-CELL PROLIFERATION 15
Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1 15
PRODUCTION OF INTERLEUKIN-1 ACTIVITY BY NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-B 14
HEMODIALYSIS RELATED INDUCTION OF INTERLEUKIN-6 PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS 14
Identification of a Btk-BAG3 complex induced by oxidative stress 14
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 14
REARRANGEMENT LEADING TO THE EXPRESSION OF A PROMOTERLESS NEO GENE SPONTANEOUSLY OR FOLLOWING MUTAGENIC TREATMENTS IN STABLY TRANSFORMED RAT-2 FIBROBLASTS 14
FUNCTIONAL INTERACTIONS OF NF-KAPPA-B FACTORS WITH NF-IL6-C/EBP TRANSCRIPTION FACTORS IN THE REGULATION OF HIV-1 LTR 13
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 13
Induction of tumorigenicity and plasmacytoid differentiation in EBV-B cells by expression of exogenous interleukin-6 or IL-6 receptor genes. 13
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 13
A NF-KAPPA-B-BINDING SITE IN TAR ENHANCES THE HIV-1 GENE-EXPRESSION IN RESPONSE TO NF-KAPPA-B ACTIVATING STIMULI 12
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 12
Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappa B (I kappa B-alpha S32/36A) and the implications for vaccine development 11
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 11
INTERLEUKIN-1-BETA MODULATION OF PROLACTIN SECRETION FROM RAT ANTERIOR-PITUITARY-CELLS - INVOLVEMENT OF ADENYLATE-CYCLASE ACTIVITY AND CALCIUM MOBILIZATION 10
null 10
Human large granular lymphocytes are potent producers of interleukin-1 9
Peptide-guided targeting of GPR55 for anti-cancer therapy 9
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 8
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk 8
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 8
Peptide-guided targeting of GPR55 for anti-cancer therapy. 8
Predictive value of Epstein-Bar virus genome copy number and BZLF1 expression in blood lyphocytes of transplant recipients at risk for lymphoproliferative disease 7
DNA-DAMAGING AGENTS INCREASE THE STABILITY OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 TRANSCRIPTS AND THE PRODUCTION OF THE RELATIVE PROTEINS 7
MIND THE MOUSE - A CONSENSUS VIEW ON THE USE OF IMMUNODEFICIENT MICE IN IMMUNOLOGY AND ONCOLOGY 7
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 7
The Human Immunodeficiency Virus Type 1 Long Terminal Repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes 7
EXPRESSION OF INTERLEUKINS IN L-CELLS TRANSFECTED WITH HUMAN DNA 6
The expression of the Interleukin-6 gene is induced by the human immunodeficiency virus Tat Protein 6
THE EXPRESSION OF THE INTERLEUKINS GENE IS INDUCED BY THE HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN 6
null 6
Impaired generation of bone marrow B lymphocytes in mice deficient of C/EBPbeta 6
Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. 5
PRODUCTION OF MULTIPLE CYTOKINES BY CLONES OF HUMAN LARGE GRANULAR LYMPHOCYTES 5
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes 5
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1 positive sera 5
TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes 5
INTERLEUKIN-6 (IL6) INDUCES PLASMACYTOID DIFFERENTIATION OF EBV-B CELLS TRANSFECTED WITH AN IL6 RECEPTOR GENE 5
HETEROGENEITY IN THE MITOGENIC RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO A PAN-T MONOCLONAL-ANTIBODY 4
HUMAN INTERLEUKIN-1 (IL-1) IS THE AUTOSTIMULATORY GROWTH-FACTOR FOR ROHA-9, AN EBV-TRANSFORMED HUMAN B-CELL LINE 4
Shc mediates IL-6 signaling by interacting with gp130 and Jaj2 kinase 3
Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. 3
Totale 1.671
Categoria #
all - tutte 22.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 8 13 1 5 2 1 2 17 45
2020/202199 18 6 1 2 10 11 12 0 19 18 1 1
2021/2022326 4 2 3 78 24 5 10 99 14 38 46 3
2022/2023872 194 24 35 62 105 91 3 67 171 59 46 15
2023/2024280 67 42 27 22 25 79 4 8 1 4 1 0
Totale 1.671